We Support Discovery Programs with Human Organ Models
We believe that human tissue models are at the very core of tomorrow’s drug discovery. Our team of world class experts in Organ-on-a-Chip modelling and screening supports decision-making from target validation through safety assessment – reducing clinical attrition and shortening timelines.
Supporting Every Phase of Pre-Clinical Drug Discovery
Our services support our clients in each phase of drug discovery
.svg)
.svg)
.svg)
.svg)
.svg){kind=icon}
Working Together, Your Way
From fast projects to multi-phase partnerships, our collaborations are designed to fit your goals. We tailor each engagement to your scientific objectives, timelines, and budget so you get exactly the support you need, when you need it.
Consultation
Understand your goals, scope, and success criteria
Study design
Select the right model setup, endpoints, and approach
Project initiation
Meet your dedicated MIMETAS scientists
Execution
Experiments performed in our state-of-the-art laboratories
Progress updates
Regular calls and interim data sharing
Final reporting
Clear summary of collected data, conclusions, and recommendations
Our Expertise for Your Research Needs
We use primary cells, organoids, and cell lines to deliver human-relevant assays. For your research, we source patient-derived materials with care and precision. In this way, we ensure every model reflects the biology that matters most to your program.
.svg){kind=icon}
.svg){kind=icon}
.svg){kind=icon}
Meet the Team
Our team combines expertise in 3D cell culture, microphysiological systems, data analysis, and pharmacology.
Ready to Advance Your Program?
Let’s discuss how MIMETAS can support your
drug discovery and development pipeline.